Home・Lista de Ações・AngioDynamics Inc

AngioDynamics Inc

Abrir

SetorSaúde

15.9 1.27

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

15.46

Máximo

15.86

Indicadores-chave
By Trading Economics
Rendimento	-3.3M -11M
Vendas	8.2M 87M
EPS	-0.07
Margem de lucro	-13.169
Funcionários	632
EBITDA	-26M -28M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+33.16% upside

Dividendos
By Acuity
Próximos Ganhos	1 de out. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	119M 648M
Abertura anterior	14.63
Fecho anterior	15.9

Sentimento de Notícias

By Acuity

50%

150 / 340 Ranking em Healthcare

AngioDynamics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

24 de ago. de 2026, 19:56 UTC

News

AngioDynamics Inc is lower today, continuing a trend of declines amid broader market pressures from recent geopolitical tensions affecting economic uncertainty.

18 de ago. de 2026, 19:16 UTC

AngioDynamics Inc is trading higher, reaching a notable intraday high. The stock remains above its 20-day moving average amid a supportive market environment.

17 de ago. de 2026, 19:41 UTC

AngioDynamics Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. The stock remains above its 20-day moving average.

13 de ago. de 2026, 20:01 UTC

AngioDynamics Inc shares are lower today, reflecting a slight decline since Wednesday's close. The stock peaked earlier in the session before pulling back.

12 de ago. de 2026, 22:02 UTC

AngioDynamics Inc shares are lower in after-market hours, with no specific news identified to explain the decline. They remain below their 20-day moving average.

11 de ago. de 2026, 19:51 UTC

AngioDynamics Inc shares are higher today, driven by a significant upward trend in the Health Care Equipment sub-sector, remaining above the 20-day moving average.

10 de ago. de 2026, 19:36 UTC

AngioDynamics Inc shares are higher since Friday's close, despite earlier declines. Broader market volatility may be influenced by fluctuations in oil prices.

7 de ago. de 2026, 19:33 UTC

News

AngioDynamics shares are rising despite a downgrade to Q3 2028 earnings estimates. Analysts from Canaccord Genuity and HC Wainwright raised their price targets.

6 de ago. de 2026, 19:56 UTC

AngioDynamics shares are lower during Thursday's session, with no specific news identified. The stock remains above its 20-day moving average.

5 de ago. de 2026, 19:46 UTC

AngioDynamics Inc shares are lower amid broader market caution following ADP's report of only 44,000 private sector jobs added in July.

4 de ago. de 2026, 19:31 UTC

AngioDynamics Inc shares are lower today, driven by significant declines in the Health Care Equipment sub-sector. No specific company news was identified.

3 de ago. de 2026, 20:02 UTC

AngioDynamics Inc shares are higher today, supported by gains in the Health Care Equipment sector. The stock remains above its 20-day moving average.

31 de jul. de 2026, 19:33 UTC

AngioDynamics shares are lower amid broader market dynamics and rising bond yields, despite remaining above the 20-day moving average.

30 de jul. de 2026, 18:56 UTC

AngioDynamics Inc. shares are trading roughly flat, remaining above their 20-day moving average after four consecutive sessions of higher closes.

29 de jul. de 2026, 19:56 UTC

Macro Event

AngioDynamics Inc shares are higher since Tuesday, reflecting volatility from the Federal Reserve's interest rate decision and easing inflation data.

28 de jul. de 2026, 20:02 UTC

News

AngioDynamics will participate in two investor conferences this week, contributing to a notable increase in shares during Tuesday's session.

27 de jul. de 2026, 19:56 UTC

AngioDynamics Inc is rising amid strength in the health care equipment sector. The stock reached a peak earlier in the session before moderating gains.

24 de jul. de 2026, 18:36 UTC

AngioDynamics Inc is trading higher today, reflecting a positive market response. The stock remains above its 20-day moving average amid no specific news.

23 de jul. de 2026, 20:03 UTC

AngioDynamics Inc. shares are lower today, reflecting a decline from Wednesday's close amid broader market weakness in tech stocks related to rising AI capital expenditures.

22 de jul. de 2026, 19:56 UTC

AngioDynamics Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. The stock remains above its 20-day moving average.

21 de jul. de 2026, 20:06 UTC

News

AngioDynamics Inc shares are higher today, supported by a strong Nasdaq 100 Index. Analysts maintain a Hold rating amid optimism for NanoKnife technology.

20 de jul. de 2026, 19:46 UTC

News

AngioDynamics shares are higher today, despite a downgrade to "strong sell" from Zacks Research and a price target increase from Canaccord Genuity to $20.00.

Comparação entre Pares

Variação de preço

AngioDynamics Inc Previsão

Preço-alvo

By TipRanks

33.16% parte superior

Previsão para 12 meses

Média 21 USD 33.16%

Máximo 24 USD

Mínimo 19 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para AngioDynamics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

3 ratings

Comprar

Manter

Vender

Com base em 3 analistas que deram avaliações de ações para AngioDynamics Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

150 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.